Immunocytochemical demonstration of pituitary adenylate cyclase activating polypeptide (PACAP) in the porcine epiphyseal cartilage canals

Neuropeptides

Volumn 31, Issue 2, 1997, Pages 137-141

  Strange Vognsen, H H ^a,c   Arnbjerg, J ^b   Hannibal, J ^a  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

^b UNIVERSITY OF COPENHAGEN   (Denmark)

^c NONE   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

CALCITONIN GENE RELATED PEPTIDE; HYPOPHYSIS ADENYLATE CYCLASE ACTIVATING POLYPEPTIDE; NEUROPEPTIDE; SUBSTANCE P; VASOACTIVE INTESTINAL POLYPEPTIDE;

ANIMAL TISSUE; ARTICLE; EPIPHYSEAL CARTILAGE; FEMALE; FEMUR HEAD; IMMUNOCYTOCHEMISTRY; MALE; NEWBORN; NONHUMAN; OSSIFICATION; PATELLA; PRIORITY JOURNAL; PROTEIN LOCALIZATION; SWINE;

ANIMALIA; SUIDAE; SUS SCROFA;

EID: 0030944068     PISSN: 01434179     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0143-4179(97)90082-2     Document Type: Article

References (36)

1. Stockwell R A. The ultrastructure of cartilage canals and surrounding cartilage in sheep fetus. J Anat 1971; 109: 379-410.
2. Willsman N J, Van Sickle D C. Cartilage canals, their morphology and distribution. Anat Rec 1972; 173: 79-93.
3. Strange-Vognsen H H, Lauersen H. Nerves in human epiphyseal uncalcified cartilage. J Fed Orthop 1996; 17-B:in press.
4. Duncan C P, Shim S S. The autonomic nerve supply of bone. J Bone Joint Surg 1977; 59B: 323-330.
5. Bjurholm A. Neuroendocrine peptides in bone. Int Orthopaedics 1991; 15: 325-329.
6. Kruger L Morphological features of thin sensory afferent fibers: A new interpretation of 'nociceptor' function. Prog Brain Res 1988; 74: 253-257.
7. Hukkanen M, Konttinen Y T, Santavirta S et al. Rapid proliferation of calcitonin gene-related peptide - immunoreactive nerves during healing of rat tibial fracture suggest neural involvement in bone growth and remodeling. Neuroscience 1993; 54: 969-979.
8. Hill E L, Turner R, Eide R. Effects of neonatal sympathectomy and capsaicin treatment on bone remodeling in rats. Neuroscience 1991; 44: 747-755.
9. Miyata A, Arimura A, Dahl R R et al. Isolation of a novel 38 residue hypothalamic polypeptide which stimulates adenylate cyclase in pituitary cells. Biochem Biophys Res Commun 1989; 164(1): 567-574.
10. Arimura A, Shioda S. Pituitary adenylate cyclase activating polypeptide (PACAP) and its receptors: neuroendocrine and endocrine interaction. Front Neuroendocrinol 1995; 16: 53-88.
11. Moller K, Zhang Y Z, Hakanson R et al. Pituitary adenylate cyclase activating peptide is a sensory neuropeptide - immunocytochemical and immunochemical evidence. Neuroscience 1993; 57: 725-732.
12. Zhang Y Z, Sjolund B, Moller K, Hakanson R, Sundler F. Pituitary adenylate cyclase activating peptide produces a marked and long-lasting depression of a C-fibre-evoked flexion reflex. Neuroscience 1993; 57: 733-737.
13. Mulder H, Uddman R, Moller K et al. Pituitary adenylate cyclase activating polypeptide expression in sensory neurons. Neuroscience 1994; 63: 307-312.
14. Zhang Y Z, Hannibal J, Zhao Q et al. Pituitary adenylate cyclase activating polypeptide (PACAP) in the rat dorsal root ganglia: Up-regulation after peripheral nerve injuries. Neuroscience 1996; 75: 1099-1110.
15. Fahrenkrug J, Hannibal J. PACAP in the rat female genital tract: Effect of capsaicin. Neuroscience 1996; 73: 1049-1060.
16. Yamamoto T, Tatsuno I. Antinociceptive effect of intrathecally administered pituitary adenylate cyclase activating polypeptide (PACAP) on the rat formalin test. Neurosci Lett 1995; 184: 32-35.
17. Suzuki A, Kotoyori J, Oiso Y, Kozawa O. Pituitary adenylate cyclase-activating polypeptide induces cAMP production independently from vasoactive intestinal polypeptide in osteoblast-like cells. Cell Signal 1994; 6: 11-16.
18. Lerner U H, Lundberg P, Ransjo M, Persson P, Hakanson R. Helodermin, helospectin, and PACAP stimulate cyclic AMP formation in intact bone, isolated osteoblasts, and osteoblastic cell lines. Calcif Tissue Int 1994; 54: 284-289.
19. Hannibal J, Mikkelsen J D, Clausen H, Holst J J, Wulff B S, Fahrenkrug J. Gene expression of pituitary adenylate cyclase activating polypeptide (PACAP) in the rat hypothalamus. Regul Pept 1995; 55: 133-148.
20. Hannibal J, Mikkelsen J D, Fahrenkrug J, Larsen P J. Pituitary adenylate cyclase-activating peptide gene expression in corticotropin-releasing factor-containing parvicellular neurons of the rat hypothalamic paraventricular nucleus is induced by colchicine, but not by adrenalectomy, acute osmotic, ether, or restraint stress. Endocrinology 1995; 136: 4116-4124.
21. Fahrenkrug J, Buhl T, Hannibal J. Prepro-PACAP-derived peptides occur in VIP-producing tumours and co-exist with VIP. Regul Pept 1995; 58: 89-98.
22. Zhang Q, Shi T, Ji R et al. Expression of pituitary adenylate cyclase activating polypeptide in dorsal root ganglia following axotomy: time course and coexistence. Brain Res 1995; 705: 149-158.
23. Minkes R K, McMahon TJ, Hood J S et al. Differential effects of PACAP and VIP on the pulmonary and hindquarters vascular beds of the cat. J Appl Physiol 1992; 72: 1212-1217.
24. Nandha K A, Benito Orfila M A, Smith D M, Ghatei M A, Bloom S R. Action of pituitary adenylate cyclase-activating polypeptide and vasoactive intestinal polypeptide on the rat vascular system: effects on blood pressure and receptor binding. J Endocrinol 1991; 129: 69-73.
25. McMahon TJ, Kadowitz P J. Analysis of responses to substance P in the pulmonary vascular bed of the cat. Am J Physiol 1993; 264: H394-H402.
26. Sawangjaroen K, Dallemagne C R, Cross R B, Curlewis J D. Effects of pituitary adenylate cyclase activating polypeptide (PACAP) and vasoactive intestinal polypeptide (VIP) on the cardiovascular system in sheep. Peptides 1992; 13: 1029-1032.
27. Absood A, Chen D, Wang Z Y, Hakanson R. Vascular effects of pituitary adenylate cyclase activating peptide: a comparison with vasoactive intestinal peptide. Regul Pept 1992; 40: 323-329.
28. Ishizuka Y, Kashimoto K, Mochizuki T, Sato K, Ohshima K, Yanaihara N. Cardiovascular and respiratory actions of pituitary adenylate cyclase-activating polypeptides. Regul Pept 1992; 40: 29-39.
29. Santiago J A, Kadowitz P J. Analysis of responses to pituitary adenylate cyclase activating polypeptide-38 in the feline hindquarters vascular bed. Eur J Pharmacol 1993; 243: 291-294.
30. Cheng D Y, McMahon T J, Dewitt B J et al. Comparison of responses to pituitary adenylate cyclase activating peptides 38 and 27 in the pulmonary vascular bed of the cat. Eur J Pharmacol 1993; 243: 79-82.
31. Ishihara T, Shigemoto R, Mori K, Takahashi K, Nagata S. Functional expression and tissue distribution of a novel receptor for vasoactive intestinal polypeptide. Neuron 1992; 8: 811-819.
32. Spengler D, Waeber C, Pantaloni C et al. Differential signal transduction by five splice variants of the PACAP receptor. Nature 1993; 365: 170-175.
33. Hashimoto H, Ishihara T, Shigemoto R, Mori K, Nagata S. Molecular cloning and tissue distribution of a receptor for pituitary adenylate cyclase-activating polypeptide. Neuron 1993; 11: 333-342.
34. Lutz E M, Sheward W J, West K M, Morrow J A, Fink G, Harmar A.J. The VIP2 receptor: molecular characterization of a cDNA encoding a novel receptor for vasoactive intestinal peptide. FEBS Lett 1993; 334: 3-8.
35. Pisegna J R, Wank S A. Molecular cloning and functional expression of the pituitary adenylate cyclase-activating polypeptide type I receptor. Proc Natl Acad Sci USA 1993; 90: 6345-6349.
36. Sisask G, Bjurholm A, Ahmed M, Kreicbergs A. Ontogeny of sensory nerves in the developing skeleton. Anat Rec 1995; 243: 234-240.